Edwards Lifesciences Management
Management criteria checks 2/4
Edwards Lifesciences' CEO is Bernard Zovighian, appointed in May 2023, has a tenure of less than a year. total yearly compensation is $12.87M, comprised of 7.6% salary and 92.4% bonuses, including company stock and options. directly owns 0.003% of the company’s shares, worth €1.49M. The average tenure of the management team and the board of directors is 4.9 years and 8.1 years respectively.
Key information
Bernard Zovighian
Chief executive officer
US$12.9m
Total compensation
| CEO salary percentage | 7.6% |
| CEO tenure | less than a year |
| CEO ownership | 0.003% |
| Management average tenure | 4.9yrs |
| Board average tenure | 8.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$1b |
| Dec 31 2023 | US$13m | US$973k | US$1b |
| Sep 30 2023 | n/a | n/a | US$1b |
| Jun 30 2023 | n/a | n/a | US$1b |
| Mar 31 2023 | n/a | n/a | US$1b |
| Dec 31 2022 | US$3m | US$642k | US$2b |
Compensation vs Market: Bernard's total compensation ($USD12.87M) is above average for companies of similar size in the German market ($USD5.58M).
Compensation vs Earnings: Bernard's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Bernard Zovighian (55 yo)
less than a year
Tenure
US$12,869,020
Compensation
Mr. Bernard J. Zovighian serves as Chief Executive Officer and Director at Edwards Lifesciences Corp since May 11, 2023 and was its President at Edwards Lifesciences Corp since January 1, 2023 until May 11...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$12.87m | 0.0030% $ 1.5m | |
| Corporate VP & CFO | 10.3yrs | US$5.95m | 0.044% $ 21.9m | |
| Corporate Vice President of Strategy & Corporate Development | 8.2yrs | US$4.29m | 0.033% $ 16.5m | |
| Corporate VP and Group President of TAVR & Surgical Structural Heart | 1.3yrs | US$5.40m | 0.033% $ 16.2m | |
| Corporate VP of Advanced Technology & Chief Scientific Officer | 5.2yrs | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Corporate VP & General Counsel | 4.6yrs | no data | no data | |
| Corporate Vice President of Public Affairs | 10.8yrs | no data | no data | |
| Corporate Vice President of Human Resources | 11.7yrs | no data | no data | |
| Senior Vice President of Quality & Regulatory Compliance | less than a year | no data | no data | |
| GM & Senior VP of Surgical Structural Heart | less than a year | no data | no data | |
| VP & Corporate Controller | no data | no data | 0.0049% $ 2.4m |
4.9yrs
Average Tenure
57.5yo
Average Age
Experienced Management: EWL's management team is considered experienced (4.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$12.87m | 0.0030% $ 1.5m | |
| Independent Director | 9.2yrs | US$335.06k | 0.011% $ 5.6m | |
| Independent Director | 3.8yrs | US$329.97k | 0.00082% $ 406.1k | |
| Non-Executive Chairman of the Board | 24.3yrs | US$2.87m | 0.67% $ 332.6m | |
| Independent Director | 8.1yrs | US$335.06k | 0.011% $ 5.6m | |
| Independent Director | 7.8yrs | US$356.42k | 0.0040% $ 2.0m | |
| Independent Director | 9.4yrs | US$347.97k | 0.011% $ 5.4m | |
| Lead Independent Director | 8.5yrs | US$364.97k | 0.0048% $ 2.4m | |
| Independent Director | 3.9yrs | US$334.97k | 0.0014% $ 678.4k |
8.1yrs
Average Tenure
65yo
Average Age
Experienced Board: EWL's board of directors are considered experienced (8.1 years average tenure).